Published in Front Psychol on November 14, 2012
Mentalizing in schizophrenia is more than just solving theory of mind tasks. Front Psychol (2013) 0.76
Evidence from paranoid schizophrenia for more than one component of theory of mind. Front Psychol (2015) 0.75
Aberrant activity and connectivity of the posterior superior temporal sulcus during social cognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Does the autistic child have a "theory of mind"? Cognition (1985) 11.88
The "Reading the Mind in the Eyes" Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry (2001) 9.51
Beliefs about beliefs: representation and constraining function of wrong beliefs in young children's understanding of deception. Cognition (1983) 7.90
Development and neurophysiology of mentalizing. Philos Trans R Soc Lond B Biol Sci (2003) 7.15
The functional significance of social cognition in schizophrenia: a review. Schizophr Bull (2006) 4.64
It's the thought that counts: specific brain regions for one component of theory of mind. Psychol Sci (2006) 3.15
Theory of mind in schizophrenia: meta-analysis. Br J Psychiatry (2007) 2.87
Frontal lobe contributions to theory of mind. J Cogn Neurosci (1998) 2.70
"Theory of mind" in schizophrenia: a review of the literature. Schizophr Bull (2005) 2.63
'Theory of mind' in the brain. Evidence from a PET scan study of Asperger syndrome. Neuroreport (1996) 2.60
Social cognition in schizophrenia. Psychol Bull (1997) 2.26
Schizophrenia, symptomatology and social inference: investigating "theory of mind" in people with schizophrenia. Schizophr Res (1995) 2.26
Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications. Brain (2002) 2.17
Theory of mind impairment in schizophrenia: meta-analysis. Schizophr Res (2009) 2.05
Social cognition in schizophrenia: an overview. Schizophr Bull (2008) 2.00
Impaired "affective theory of mind" is associated with right ventromedial prefrontal damage. Cogn Behav Neurol (2005) 1.70
Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome. Schizophr Res (2010) 1.50
Social threat perception and the evolution of paranoia. Neurosci Biobehav Rev (2004) 1.45
Schizophrenia and theory of mind. Psychol Med (2004) 1.45
Theory of mind performance in schizophrenia: diagnostic, symptom, and neuropsychological correlates. J Nerv Ment Dis (2004) 1.41
Mentalising, schizotypy, and schizophrenia. Cognition (1999) 1.39
"Theory of mind" impairments and their relationship to executive functioning following frontal lobe excisions. Brain (2001) 1.38
Social cognition in frontotemporal dementia and Huntington's disease. Neuropsychologia (2003) 1.37
Introducing MASC: a movie for the assessment of social cognition. J Autism Dev Disord (2006) 1.31
Persecutory beliefs, attributions and theory of mind: comparison of patients with paranoid delusions, Asperger's syndrome and healthy controls. Schizophr Res (2004) 1.23
Dissociation of cognitive from affective components of theory of mind in schizophrenia. Psychiatry Res (2006) 1.22
Theory of mind impairments in schizophrenia: symptomatology, severity and specificity. Psychol Med (2001) 1.20
Theory of mind deficits for processing counterfactual information in persons with chronic schizophrenia. Psychol Med (2008) 1.18
Theory of mind impairment: a distinct trait-marker for schizophrenia spectrum disorders and bipolar disorder? Acta Psychiatr Scand (2009) 1.17
A neurobiological mapping of theory of mind. Brain Res Brain Res Rev (2003) 1.13
Deficits of social-cognitive and social-perceptual aspects of theory of mind in remitted patients with schizophrenia: effect of residual symptoms. J Nerv Ment Dis (2008) 1.11
An fMRI study of theory of mind in schizophrenic patients with "passivity" symptoms. Neuropsychologia (2008) 1.08
The appreciation of visual jokes in people with schizophrenia: a study of 'mentalizing' ability. Schizophr Res (1997) 1.07
Different aspects of theory of mind in paranoid schizophrenia: evidence from a video-based assessment. Psychiatry Res (2010) 1.07
Theory of mind and the role of IQ in chronic disorganized schizophrenia. Schizophr Res (2003) 1.06
Faux pas detection and intentional action in Asperger Syndrome. A replication on a French sample. J Autism Dev Disord (2008) 1.06
The getting of wisdom: theory of mind in old age. Dev Psychol (1998) 1.06
The possibility of different forms of theory of mind impairment in psychiatric and developmental disorders. Psychol Med (2000) 1.03
Attention, theory of mind, and causal attributions in people with persecutory delusions: A preliminary investigation. Cogn Neuropsychiatry (2003) 1.03
The cognitive basis of disorganization symptomatology in schizophrenia and its clinical correlates: toward a pathogenetic approach to disorganization. Schizophr Bull (2003) 1.03
Validity of the Ward seven-subtest WAIS-III short form in a neuropsychological population. Appl Neuropsychol (1999) 1.00
Externalizing and personalizing biases in persecutory delusions: the relationship with poor insight and theory-of-mind. Behav Res Ther (2005) 1.00
Symptomatology and social inference: a theory of mind study of schizophrenia and psychotic affective disorder. Cogn Neuropsychiatry (2005) 0.99
Elementary neurocognitive function, facial affect recognition and social-skills in schizophrenia. Schizophr Res (2009) 0.98
Emotion processing and theory of mind in schizophrenia patients and their unaffected first-degree relatives. Neuropsychologia (2009) 0.97
Theory of mind and its relation to schizotypy. Cogn Neuropsychiatry (2006) 0.97
Theory of mind and motion perception in schizophrenia. Neuropsychology (2005) 0.96
Impaired theory of mind in first-episode schizophrenia: comparison with community, university and depressed controls. Schizophr Res (2007) 0.96
Proverb comprehension reconsidered--'theory of mind' and the pragmatic use of language in schizophrenia. Schizophr Res (2004) 0.95
Beyond Simulation-Theory and Theory-Theory: why social cognitive neuroscience should use its own concepts to study "theory of mind". Cognition (2007) 0.94
Subtle deficits of cognitive theory of mind in unaffected first-degree relatives of schizophrenia patients. Eur Arch Psychiatry Clin Neurosci (2011) 0.94
Theory of mind and frontal lobe pathology in schizophrenia: a voxel-based morphometry study. Schizophr Res (2008) 0.94
The detection of intentional contingencies in simple animations in patients with delusions of persecution. Psychol Med (2003) 0.93
Quantitative assessment of attribution of intentions to others in schizophrenia using an ecological video-based task: a comparison with manic and depressed patients. Psychiatry Res (2009) 0.92
Inductive reasoning and the understanding of intention in schizophrenia. Cogn Neuropsychiatry (2003) 0.86
Schizophrenia, theory of mind, and persecutory delusions. Cogn Neuropsychiatry (2005) 0.86
Th.o.m.a.s.: an exploratory assessment of Theory of Mind in schizophrenic subjects. Conscious Cogn (2008) 0.86
Are theory of mind deficits in understanding intentions of others associated with persecutory delusions? J Nerv Ment Dis (2010) 0.83
Assessment of social cognition in patients with multiple sclerosis. J Int Neuropsychol Soc (2010) 0.83
Sense of agency and mentalizing: dissociation of subdomains of social cognition in patients with schizophrenia. Psychiatry Res (2010) 0.82
Social performance is more closely associated with theory of mind and autobiographical memory than with psychopathological symptoms in clinically stable patients with schizophrenia-spectrum disorders. Psychiatry Res (2010) 0.82
Deficits in theory of mind and social anxiety as independent paths to paranoid features in schizophrenia. Schizophr Res (2010) 0.82
Context-sensitive social cognition is impaired in schizophrenic patients and their healthy relatives. Schizophr Res (2009) 0.81
Working memory and multi-tasking in paranoid schizophrenia with and without comorbid substance use disorder. Addiction (2008) 0.81
Positive and negative symptoms and the thematic organisation of schizophrenic speech. Br J Psychiatry (1984) 0.81
Schizophrenia and the response to facial emotions. Compr Psychiatry (1980) 0.78
Separating component processes of theory of mind in schizophrenia. Br J Clin Psychol (2009) 0.78
The impact of impaired "Theory of Mind" on social interactions in schizophrenia. J Int Neuropsychol Soc (2011) 0.77
Schizophrenic and depressed inpatients' perceptions of congruent and incongruent communications. J Clin Psychol (1985) 0.77
Interpretation of congruent and incongruent affective communications in paranoid schizophrenia. Br J Clin Psychol (2001) 0.76
Impaired comprehension of nonliteral language in Tourette syndrome. Cogn Behav Neurol (2010) 0.76
Psychological variables and flattening of affect. Br J Med Psychol (1974) 0.75
Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med (2006) 4.16
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry (2007) 3.22
Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. J Clin Psychiatry (2007) 2.13
The crossover approach to switching antipsychotics: what is the evidence? Schizophr Res (2005) 1.55
Preserved awareness of their cognitive deficits in patients with schizophrenia: convergent validity of the SSTICS. Schizophr Res (2008) 1.48
Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis. Drug Saf (2012) 1.42
Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull (2004) 1.31
Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis. Can J Psychiatry (2008) 1.09
Assessment of executive dysfunction during activities of daily living in schizophrenia. Schizophr Res (2004) 1.07
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder. J Clin Psychiatry (2011) 1.06
Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? Schizophr Res (2008) 1.06
Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophr Res (2005) 1.04
Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program. Schizophr Res (2004) 1.04
Cerebral activity associated with auditory verbal hallucinations: a functional magnetic resonance imaging case study. J Psychiatry Neurosci (2002) 1.01
Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. Eur Psychiatry (2007) 1.01
CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain Cogn (2005) 1.00
Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review. Schizophr Res Treatment (2012) 1.00
Predictors of quality of life in schizophrenia. Community Ment Health J (2005) 1.00
Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. J Psychiatry Neurosci (2007) 0.99
Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophr Res (2007) 0.98
Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia. Schizophr Res (2003) 0.98
Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized study. Schizophr Res (2009) 0.97
Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders. Eur Arch Psychiatry Clin Neurosci (2014) 0.95
The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency. Can J Psychiatry (2004) 0.94
Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf (2008) 0.93
Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study. Psychiatry Res (2005) 0.92
Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology (Berl) (2003) 0.92
Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization. J Psychiatr Res (2008) 0.90
ERP investigation of study-test background mismatch during face recognition in schizophrenia. Schizophr Res (2011) 0.89
Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Curr Med Res Opin (2007) 0.89
Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? Expert Rev Neurother (2011) 0.89
Pain perception in schizophrenia: evidence of a specific pain response profile. Pain Med (2012) 0.88
Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials. Int Clin Psychopharmacol (2011) 0.88
Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control. Can J Psychiatry (2007) 0.88
Neural correlates of emotional recognition memory in schizophrenia: effects of valence and arousal. Psychiatry Res (2011) 0.87
Agenesis of corpus callosum and emotional information processing in schizophrenia. Front Psychiatry (2012) 0.87
Differential hemodynamic brain activity in schizophrenia patients with blunted affect during quetiapine treatment. J Clin Psychopharmacol (2005) 0.87
Sleep habits in middle-aged, non-hospitalized men and women with schizophrenia: a comparison with healthy controls. Psychiatry Res (2010) 0.87
An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis. Clin Schizophr Relat Psychoses (2013) 0.86
Daily activities, cognition and community functioning in persons with schizophrenia. Schizophr Res (2008) 0.85
Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients. Psychiatry Res (2012) 0.85
Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis. Schizophr Res (2009) 0.85
Attention and non-REM sleep in neuroleptic-naive persons with schizophrenia and control participants. Psychiatry Res (2006) 0.85
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. J Psychopharmacol (2008) 0.84
Do patients with schizophrenia attribute mental states in a referential communication task? Cogn Neuropsychiatry (2009) 0.84
Memory and executive functions in adults with Gilles de la Tourette syndrome and chronic tic disorder. Cogn Neuropsychiatry (2007) 0.84
The incidence and nature of cerebellar findings in schizophrenia: a quantitative review of fMRI literature. Schizophr Bull (2012) 0.84
The crucial role of sustained attention in community functioning in outpatients with schizophrenia. Psychiatry Res (2004) 0.84
Use of the process dissociation procedure to study the contextual effects on face recognition in schizophrenia: familiarity, associative recollection and discriminative recollection. Psychiatry Res (2006) 0.84
Relationship between psychotic and obsessive compulsive symptoms in schizophrenia. Schizophr Res (2009) 0.84
Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study. Soc Neurosci (2007) 0.83
Mild procedural learning disturbances in neuroleptic-naive patients with schizophrenia. J Neuropsychiatry Clin Neurosci (2003) 0.83
Assessment of social cognition in patients with multiple sclerosis. J Int Neuropsychol Soc (2010) 0.83
Electrophysiological manifestations of stimulus evaluation, response inhibition and motor processing in Tourette syndrome patients. Psychiatry Res (2009) 0.82
Procedural learning in schizophrenia can reflect the pharmacologic properties of the antipsychotic treatments. Cogn Behav Neurol (2004) 0.82
Genealogy of instruments for prodrome evaluation of psychosis. Front Psychiatry (2013) 0.82
Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders. Schizophr Res (2005) 0.82
Sex differences in the cerebral function associated with processing of aversive stimuli by schizophrenia patients. Aust N Z J Psychiatry (2007) 0.82
Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis. J Clin Psychopharmacol (2010) 0.82
[The role of social support, family burden and satisfaction with services in psychological distress and quality of life of families of individuals with schizophrenia]. Sante Ment Que (2005) 0.82
Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia. Mov Disord (2010) 0.81
Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. Expert Opin Drug Saf (2012) 0.81
Language functions in right-hemisphere damage and schizophrenia: apparently similar pragmatic deficits may hide profound differences. Brain (2007) 0.81
Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Curr Med Res Opin (2006) 0.81
Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. Am J Drug Alcohol Abuse (2008) 0.81
Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study. Psychiatry Res (2007) 0.81
Sexual dimorphism of spatial working memory profiles in schizophrenia. Cogn Neuropsychiatry (2010) 0.81
Are there common mechanisms in sensation seeking and reality distortion in schizophrenia? A study using memory event-related potentials. Psychiatry Res (2005) 0.80
Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. Aust N Z J Psychiatry (2007) 0.80
Genes and memory: the neuroanatomical correlates of emotional memory in monozygotic twin discordant for schizophrenia. Brain Cogn (2004) 0.80
Quetiapine augmentation of treatment-resistant depression: a comparison with lithium. Curr Med Res Opin (2007) 0.80
Brain-behavior relations during motor processing in chronic tic and habit disorder. Cogn Behav Neurol (2005) 0.80
Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. Cogn Neuropsychiatry (2008) 0.79
Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses. Int Clin Psychopharmacol (2003) 0.79
Temperament and executive dysfunctions in schizophrenia. Schizophr Res (2008) 0.79
ERP study of pre-attentive auditory processing in treatment-refractory schizophrenia. Brain Cogn (2004) 0.79
Mismatched expressions decrease face recognition and corresponding ERP old/new effects in schizophrenia. Neuropsychology (2012) 0.79
Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I. Clin Neuropharmacol (2007) 0.79
Decrease in basal ganglia grey matter density associated with atypical antipsychotic treatment in schizophrenia patients. Schizophr Res (2008) 0.79
Use of the Perceive, Recall, Plan and Perform System of Task Analysis for persons with schizophrenia: a preliminary study. Aust Occup Ther J (2009) 0.79
The relationships between symptom dimensions and dysphoria in schizophrenia. Schizophr Res (2005) 0.79
Experimental disentangling of spatial-compatibility and interhemispheric-relay effects in simple reaction time (Poffenberger paradigm). Exp Brain Res (2004) 0.79
Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study. J Clin Psychiatry (2006) 0.79
Ecological assessments of activities of daily living and personal experiences with Mobus, an assistive technology for cognition: a pilot study in schizophrenia. Assist Technol (2012) 0.79
Cognitive behavioral management of Tourette's syndrome and chronic tic disorder in medicated and unmedicated samples. Behav Res Ther (2009) 0.79
Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial. Expert Opin Pharmacother (2010) 0.79
The paradox of quetiapine in obsessive-compulsive disorder. CNS Spectr (2005) 0.79
Relationship between insight into cognition, extrapyramidal symptoms and mental illness in schizophrenia. Aust N Z J Psychiatry (2011) 0.78
Progesterone and Cerebral Function during Emotion Processing in Men and Women with Schizophrenia. Schizophr Res Treatment (2012) 0.78
Cognitive-behaviour therapy and skilled motor performance in adults with chronic tic disorder. Neuropsychol Rehabil (2008) 0.78
Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disorders. Schizophr Res (2011) 0.78
Influence of comorbid obsessive-compulsive symptoms on brain event-related potentials in Gilles de la Tourette syndrome. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.78
Quetiapine blocks cocaine-induced enhancement of brain stimulation reward. Behav Brain Res (2009) 0.78
A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol Med (2006) 0.78
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. Front Psychiatry (2012) 0.78
[Implementation of the multi-site Integrated Psychological Treatment (IPT) program for people with schizophrenia. Elaboration of renewed version]. Sante Ment Que (2005) 0.78
Neuropsychological and activity of daily living script performance in patients with positive or negative schizophrenia. Compr Psychiatry (2007) 0.77
[In Process Citation]. Sante Ment Que (2014) 0.77
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine. Front Psychiatry (2011) 0.77
Subjective and Objective Cognitive Dysfunction in Schizophrenia - is there a Link? Front Psychol (2011) 0.77